JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, J. I.
Right arrow Articles by Cotten, M. Dev.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, J. I.
Right arrow Articles by Cotten, M. Dev.
Journal of Pharmacology And Experimental Therapeutics, Vol. 152, Issue 3, 488-500, 1966
Copyright © 1966 by American Society for Pharmacology and Experimental Therapeutics


CARDIOVASCULAR FUNCTION, OXYGEN EXTRACTION AND LABILE NUCLEOTIDE CONTENT OF CARDIAC MUSCLE DURING NOREPINEPHRINE-INDUCED DEPRESSION OF DIGITALIZED, HYPOTHERMIC DOG HEART MUSCLE

Joanne I. Moore 1 and Marion Dev. Cotten 1

1 Department of Pharmacology, University of Oklahoma School of Medicine, Oklahoma City, Oklahoma, and Department of Pharmacology, Emory University, Atlanta, Georgia

In the hypothermic dog heart-lung preparation, norepinephnine causes a triphasic contractile force pattern characterized by an initial, brief increase in contractile force, a transient decrease in contractile force and a final prolonged increase in contractile force. These triphasic changes are reflected in the cardiac output, systolic blood pressure and left atnial pressure, and are similar to those observed in vivo. During hypothermia, ouabain increases contractile force and cardiac output and decreases left atrial pressure. Ouabain also blocks the two stimulant responses to norepinephnine and enhances the depressant response to norepinephrine. These effects of norepinephnine before and after ouabain are not caused by changes in cardiac rhythm, coronary flow, extraction of oxygen, cardiac content of adenosine triphosphate and creatine phosphate or peripheral vascular reactivity. Infusion of norepinephnine in vivo at 38°C only increases force, but at 28-30° causes a triphasic response characterized by a brief increase in force, persistence of the phase of cardiac depression throughout the infusion and development of the third (stimulant) phase only after the infusion is stopped. Infusion of norepinephrine after ouabain causes only cardiac depression. These data suggest that two distinct processes are involved in the responses to norepinephrine during hypothermia, one producing a positive inotropic response and the other a negative inotropic response.

Accepted on December 28, 1965







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics.